Answers are grounded in this paper and cite their sources.
Although pharmacokinetic and pharmacodynamic models of remimazolam have been developed, their clinical application remains limited. This study aimed to administer a target-controlled infusion (TCI) of remimazolam at the effect-site concentration (Ce) in patients undergoing general anesthesia and to investigate the relationship of the remimazolam Ce with sedative effects and with recovery from general anesthesia.
No takes yet. Share an insight, caveat, or question.
Chon et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: